nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—FMO1—Tamoxifen—pancreatic cancer	0.28	0.364	CbGbCtD
Voriconazole—FMO3—Tamoxifen—pancreatic cancer	0.175	0.228	CbGbCtD
Voriconazole—CYP3A7—Tamoxifen—pancreatic cancer	0.0235	0.0305	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0235	0.0305	CbGbCtD
Voriconazole—CYP2B6—Tamoxifen—pancreatic cancer	0.0223	0.0291	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.018	0.0234	CbGbCtD
Voriconazole—CYP3A7—Irinotecan—pancreatic cancer	0.018	0.0234	CbGbCtD
Voriconazole—CYP3A5—Tamoxifen—pancreatic cancer	0.0176	0.0229	CbGbCtD
Voriconazole—CYP2B6—Irinotecan—pancreatic cancer	0.0171	0.0223	CbGbCtD
Voriconazole—CYP3A5—Erlotinib—pancreatic cancer	0.015	0.0195	CbGbCtD
Voriconazole—CYP2C19—Tamoxifen—pancreatic cancer	0.0142	0.0185	CbGbCtD
Voriconazole—CYP3A5—Irinotecan—pancreatic cancer	0.0135	0.0176	CbGbCtD
Voriconazole—CYP3A7—Docetaxel—pancreatic cancer	0.0132	0.0172	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0132	0.0172	CbGbCtD
Voriconazole—CYP3A7—Sunitinib—pancreatic cancer	0.0131	0.0171	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0131	0.0171	CbGbCtD
Voriconazole—CYP2C9—Tamoxifen—pancreatic cancer	0.0118	0.0153	CbGbCtD
Voriconazole—CYP3A5—Docetaxel—pancreatic cancer	0.0099	0.0129	CbGbCtD
Voriconazole—CYP3A5—Sunitinib—pancreatic cancer	0.00985	0.0128	CbGbCtD
Voriconazole—CYP2B6—Doxorubicin—pancreatic cancer	0.00937	0.0122	CbGbCtD
Voriconazole—CYP2C9—Fluorouracil—pancreatic cancer	0.00869	0.0113	CbGbCtD
Voriconazole—CYP3A4—Tamoxifen—pancreatic cancer	0.00686	0.00893	CbGbCtD
Voriconazole—CYP3A4—Erlotinib—pancreatic cancer	0.00583	0.00759	CbGbCtD
Voriconazole—CYP3A4—Irinotecan—pancreatic cancer	0.00527	0.00685	CbGbCtD
Voriconazole—CYP3A4—Docetaxel—pancreatic cancer	0.00386	0.00502	CbGbCtD
Voriconazole—CYP3A4—Sunitinib—pancreatic cancer	0.00384	0.005	CbGbCtD
Voriconazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00288	0.00374	CbGbCtD
Voriconazole—Asthenia—Gemcitabine—pancreatic cancer	6.48e-05	0.00028	CcSEcCtD
Voriconazole—Haematuria—Epirubicin—pancreatic cancer	6.47e-05	0.000279	CcSEcCtD
Voriconazole—Confusional state—Docetaxel—pancreatic cancer	6.47e-05	0.000279	CcSEcCtD
Voriconazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	6.43e-05	0.000278	CcSEcCtD
Voriconazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	6.42e-05	0.000277	CcSEcCtD
Voriconazole—Oedema—Docetaxel—pancreatic cancer	6.41e-05	0.000277	CcSEcCtD
Voriconazole—Anaphylactic shock—Docetaxel—pancreatic cancer	6.41e-05	0.000277	CcSEcCtD
Voriconazole—Epistaxis—Epirubicin—pancreatic cancer	6.4e-05	0.000276	CcSEcCtD
Voriconazole—Pruritus—Gemcitabine—pancreatic cancer	6.39e-05	0.000276	CcSEcCtD
Voriconazole—Infection—Docetaxel—pancreatic cancer	6.37e-05	0.000275	CcSEcCtD
Voriconazole—Sinusitis—Epirubicin—pancreatic cancer	6.36e-05	0.000275	CcSEcCtD
Voriconazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	6.35e-05	0.000274	CcSEcCtD
Voriconazole—Diarrhoea—Irinotecan—pancreatic cancer	6.35e-05	0.000274	CcSEcCtD
Voriconazole—Agranulocytosis—Epirubicin—pancreatic cancer	6.33e-05	0.000274	CcSEcCtD
Voriconazole—Pneumonia—Doxorubicin—pancreatic cancer	6.31e-05	0.000273	CcSEcCtD
Voriconazole—Shock—Docetaxel—pancreatic cancer	6.31e-05	0.000273	CcSEcCtD
Voriconazole—Nervous system disorder—Docetaxel—pancreatic cancer	6.29e-05	0.000272	CcSEcCtD
Voriconazole—Pruritus—Fluorouracil—pancreatic cancer	6.29e-05	0.000272	CcSEcCtD
Voriconazole—Thrombocytopenia—Docetaxel—pancreatic cancer	6.28e-05	0.000271	CcSEcCtD
Voriconazole—Infestation NOS—Doxorubicin—pancreatic cancer	6.28e-05	0.000271	CcSEcCtD
Voriconazole—Infestation—Doxorubicin—pancreatic cancer	6.28e-05	0.000271	CcSEcCtD
Voriconazole—Tachycardia—Docetaxel—pancreatic cancer	6.26e-05	0.00027	CcSEcCtD
Voriconazole—Skin disorder—Docetaxel—pancreatic cancer	6.23e-05	0.000269	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	6.22e-05	0.000269	CcSEcCtD
Voriconazole—Bradycardia—Epirubicin—pancreatic cancer	6.2e-05	0.000268	CcSEcCtD
Voriconazole—Diarrhoea—Gemcitabine—pancreatic cancer	6.18e-05	0.000267	CcSEcCtD
Voriconazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	6.15e-05	0.000266	CcSEcCtD
Voriconazole—Dizziness—Irinotecan—pancreatic cancer	6.14e-05	0.000265	CcSEcCtD
Voriconazole—Stomatitis—Doxorubicin—pancreatic cancer	6.12e-05	0.000264	CcSEcCtD
Voriconazole—Jaundice—Doxorubicin—pancreatic cancer	6.12e-05	0.000264	CcSEcCtD
Voriconazole—Anorexia—Docetaxel—pancreatic cancer	6.11e-05	0.000264	CcSEcCtD
Voriconazole—Rhinitis—Epirubicin—pancreatic cancer	6.11e-05	0.000264	CcSEcCtD
Voriconazole—Urinary tract infection—Doxorubicin—pancreatic cancer	6.1e-05	0.000264	CcSEcCtD
Voriconazole—Conjunctivitis—Doxorubicin—pancreatic cancer	6.1e-05	0.000264	CcSEcCtD
Voriconazole—Hepatitis—Epirubicin—pancreatic cancer	6.09e-05	0.000263	CcSEcCtD
Voriconazole—Diarrhoea—Fluorouracil—pancreatic cancer	6.08e-05	0.000263	CcSEcCtD
Voriconazole—Hypoaesthesia—Epirubicin—pancreatic cancer	6.06e-05	0.000262	CcSEcCtD
Voriconazole—Pharyngitis—Epirubicin—pancreatic cancer	6.04e-05	0.000261	CcSEcCtD
Voriconazole—Sweating—Doxorubicin—pancreatic cancer	6.02e-05	0.00026	CcSEcCtD
Voriconazole—Urinary tract disorder—Epirubicin—pancreatic cancer	6.01e-05	0.00026	CcSEcCtD
Voriconazole—Oedema peripheral—Epirubicin—pancreatic cancer	6e-05	0.000259	CcSEcCtD
Voriconazole—Hypotension—Docetaxel—pancreatic cancer	5.99e-05	0.000259	CcSEcCtD
Voriconazole—Haematuria—Doxorubicin—pancreatic cancer	5.98e-05	0.000259	CcSEcCtD
Voriconazole—Connective tissue disorder—Epirubicin—pancreatic cancer	5.98e-05	0.000259	CcSEcCtD
Voriconazole—Urethral disorder—Epirubicin—pancreatic cancer	5.97e-05	0.000258	CcSEcCtD
Voriconazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	5.94e-05	0.000256	CcSEcCtD
Voriconazole—Epistaxis—Doxorubicin—pancreatic cancer	5.92e-05	0.000256	CcSEcCtD
Voriconazole—Vomiting—Irinotecan—pancreatic cancer	5.9e-05	0.000255	CcSEcCtD
Voriconazole—Sinusitis—Doxorubicin—pancreatic cancer	5.89e-05	0.000254	CcSEcCtD
Voriconazole—Dizziness—Fluorouracil—pancreatic cancer	5.88e-05	0.000254	CcSEcCtD
Voriconazole—Visual impairment—Epirubicin—pancreatic cancer	5.87e-05	0.000254	CcSEcCtD
Voriconazole—Agranulocytosis—Doxorubicin—pancreatic cancer	5.86e-05	0.000253	CcSEcCtD
Voriconazole—Rash—Irinotecan—pancreatic cancer	5.85e-05	0.000253	CcSEcCtD
Voriconazole—Dermatitis—Irinotecan—pancreatic cancer	5.85e-05	0.000253	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.84e-05	0.000253	CcSEcCtD
Voriconazole—Headache—Irinotecan—pancreatic cancer	5.81e-05	0.000251	CcSEcCtD
Voriconazole—Insomnia—Docetaxel—pancreatic cancer	5.8e-05	0.000251	CcSEcCtD
Voriconazole—Paraesthesia—Docetaxel—pancreatic cancer	5.76e-05	0.000249	CcSEcCtD
Voriconazole—Erythema multiforme—Epirubicin—pancreatic cancer	5.76e-05	0.000249	CcSEcCtD
Voriconazole—Vomiting—Gemcitabine—pancreatic cancer	5.75e-05	0.000248	CcSEcCtD
Voriconazole—Bradycardia—Doxorubicin—pancreatic cancer	5.74e-05	0.000248	CcSEcCtD
Voriconazole—Dyspnoea—Docetaxel—pancreatic cancer	5.72e-05	0.000247	CcSEcCtD
Voriconazole—Somnolence—Docetaxel—pancreatic cancer	5.7e-05	0.000246	CcSEcCtD
Voriconazole—Rash—Gemcitabine—pancreatic cancer	5.7e-05	0.000246	CcSEcCtD
Voriconazole—Dermatitis—Gemcitabine—pancreatic cancer	5.69e-05	0.000246	CcSEcCtD
Voriconazole—Eye disorder—Epirubicin—pancreatic cancer	5.69e-05	0.000246	CcSEcCtD
Voriconazole—Tinnitus—Epirubicin—pancreatic cancer	5.68e-05	0.000245	CcSEcCtD
Voriconazole—Headache—Gemcitabine—pancreatic cancer	5.66e-05	0.000245	CcSEcCtD
Voriconazole—Flushing—Epirubicin—pancreatic cancer	5.65e-05	0.000244	CcSEcCtD
Voriconazole—Cardiac disorder—Epirubicin—pancreatic cancer	5.65e-05	0.000244	CcSEcCtD
Voriconazole—Vomiting—Fluorouracil—pancreatic cancer	5.65e-05	0.000244	CcSEcCtD
Voriconazole—Rhinitis—Doxorubicin—pancreatic cancer	5.65e-05	0.000244	CcSEcCtD
Voriconazole—Dyspepsia—Docetaxel—pancreatic cancer	5.65e-05	0.000244	CcSEcCtD
Voriconazole—Hepatitis—Doxorubicin—pancreatic cancer	5.63e-05	0.000243	CcSEcCtD
Voriconazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	5.61e-05	0.000242	CcSEcCtD
Voriconazole—Rash—Fluorouracil—pancreatic cancer	5.6e-05	0.000242	CcSEcCtD
Voriconazole—Dermatitis—Fluorouracil—pancreatic cancer	5.6e-05	0.000242	CcSEcCtD
Voriconazole—Pharyngitis—Doxorubicin—pancreatic cancer	5.59e-05	0.000242	CcSEcCtD
Voriconazole—Decreased appetite—Docetaxel—pancreatic cancer	5.58e-05	0.000241	CcSEcCtD
Voriconazole—Headache—Fluorouracil—pancreatic cancer	5.57e-05	0.000241	CcSEcCtD
Voriconazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	5.56e-05	0.00024	CcSEcCtD
Voriconazole—Oedema peripheral—Doxorubicin—pancreatic cancer	5.55e-05	0.00024	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.54e-05	0.000239	CcSEcCtD
Voriconazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	5.54e-05	0.000239	CcSEcCtD
Voriconazole—Angiopathy—Epirubicin—pancreatic cancer	5.52e-05	0.000239	CcSEcCtD
Voriconazole—Urethral disorder—Doxorubicin—pancreatic cancer	5.52e-05	0.000239	CcSEcCtD
Voriconazole—Nausea—Irinotecan—pancreatic cancer	5.51e-05	0.000238	CcSEcCtD
Voriconazole—Immune system disorder—Epirubicin—pancreatic cancer	5.5e-05	0.000238	CcSEcCtD
Voriconazole—Mediastinal disorder—Epirubicin—pancreatic cancer	5.49e-05	0.000237	CcSEcCtD
Voriconazole—Constipation—Docetaxel—pancreatic cancer	5.49e-05	0.000237	CcSEcCtD
Voriconazole—Pain—Docetaxel—pancreatic cancer	5.49e-05	0.000237	CcSEcCtD
Voriconazole—Chills—Epirubicin—pancreatic cancer	5.46e-05	0.000236	CcSEcCtD
Voriconazole—Arrhythmia—Epirubicin—pancreatic cancer	5.44e-05	0.000235	CcSEcCtD
Voriconazole—Visual impairment—Doxorubicin—pancreatic cancer	5.43e-05	0.000235	CcSEcCtD
Voriconazole—Alopecia—Epirubicin—pancreatic cancer	5.38e-05	0.000233	CcSEcCtD
Voriconazole—Nausea—Gemcitabine—pancreatic cancer	5.37e-05	0.000232	CcSEcCtD
Voriconazole—Mental disorder—Epirubicin—pancreatic cancer	5.34e-05	0.000231	CcSEcCtD
Voriconazole—Erythema multiforme—Doxorubicin—pancreatic cancer	5.33e-05	0.00023	CcSEcCtD
Voriconazole—Erythema—Epirubicin—pancreatic cancer	5.3e-05	0.000229	CcSEcCtD
Voriconazole—Malnutrition—Epirubicin—pancreatic cancer	5.3e-05	0.000229	CcSEcCtD
Voriconazole—Feeling abnormal—Docetaxel—pancreatic cancer	5.29e-05	0.000228	CcSEcCtD
Voriconazole—Nausea—Fluorouracil—pancreatic cancer	5.28e-05	0.000228	CcSEcCtD
Voriconazole—Eye disorder—Doxorubicin—pancreatic cancer	5.27e-05	0.000228	CcSEcCtD
Voriconazole—Tinnitus—Doxorubicin—pancreatic cancer	5.25e-05	0.000227	CcSEcCtD
Voriconazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	5.25e-05	0.000227	CcSEcCtD
Voriconazole—Cardiac disorder—Doxorubicin—pancreatic cancer	5.23e-05	0.000226	CcSEcCtD
Voriconazole—Flushing—Doxorubicin—pancreatic cancer	5.23e-05	0.000226	CcSEcCtD
Voriconazole—Flatulence—Epirubicin—pancreatic cancer	5.22e-05	0.000226	CcSEcCtD
Voriconazole—Dysgeusia—Epirubicin—pancreatic cancer	5.19e-05	0.000224	CcSEcCtD
Voriconazole—Back pain—Epirubicin—pancreatic cancer	5.13e-05	0.000222	CcSEcCtD
Voriconazole—Angiopathy—Doxorubicin—pancreatic cancer	5.11e-05	0.000221	CcSEcCtD
Voriconazole—Muscle spasms—Epirubicin—pancreatic cancer	5.1e-05	0.00022	CcSEcCtD
Voriconazole—Immune system disorder—Doxorubicin—pancreatic cancer	5.09e-05	0.00022	CcSEcCtD
Voriconazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	5.08e-05	0.000219	CcSEcCtD
Voriconazole—Abdominal pain—Docetaxel—pancreatic cancer	5.07e-05	0.000219	CcSEcCtD
Voriconazole—Body temperature increased—Docetaxel—pancreatic cancer	5.07e-05	0.000219	CcSEcCtD
Voriconazole—Chills—Doxorubicin—pancreatic cancer	5.06e-05	0.000218	CcSEcCtD
Voriconazole—Arrhythmia—Doxorubicin—pancreatic cancer	5.03e-05	0.000217	CcSEcCtD
Voriconazole—Vision blurred—Epirubicin—pancreatic cancer	5e-05	0.000216	CcSEcCtD
Voriconazole—Alopecia—Doxorubicin—pancreatic cancer	4.98e-05	0.000215	CcSEcCtD
Voriconazole—Mental disorder—Doxorubicin—pancreatic cancer	4.94e-05	0.000213	CcSEcCtD
Voriconazole—Ill-defined disorder—Epirubicin—pancreatic cancer	4.92e-05	0.000213	CcSEcCtD
Voriconazole—Malnutrition—Doxorubicin—pancreatic cancer	4.9e-05	0.000212	CcSEcCtD
Voriconazole—Erythema—Doxorubicin—pancreatic cancer	4.9e-05	0.000212	CcSEcCtD
Voriconazole—Anaemia—Epirubicin—pancreatic cancer	4.9e-05	0.000212	CcSEcCtD
Voriconazole—Agitation—Epirubicin—pancreatic cancer	4.87e-05	0.00021	CcSEcCtD
Voriconazole—Flatulence—Doxorubicin—pancreatic cancer	4.83e-05	0.000209	CcSEcCtD
Voriconazole—Dysgeusia—Doxorubicin—pancreatic cancer	4.8e-05	0.000208	CcSEcCtD
Voriconazole—Malaise—Epirubicin—pancreatic cancer	4.78e-05	0.000207	CcSEcCtD
Voriconazole—Vertigo—Epirubicin—pancreatic cancer	4.76e-05	0.000206	CcSEcCtD
Voriconazole—Syncope—Epirubicin—pancreatic cancer	4.75e-05	0.000205	CcSEcCtD
Voriconazole—Leukopenia—Epirubicin—pancreatic cancer	4.75e-05	0.000205	CcSEcCtD
Voriconazole—Back pain—Doxorubicin—pancreatic cancer	4.74e-05	0.000205	CcSEcCtD
Voriconazole—Hypersensitivity—Docetaxel—pancreatic cancer	4.73e-05	0.000204	CcSEcCtD
Voriconazole—Muscle spasms—Doxorubicin—pancreatic cancer	4.72e-05	0.000204	CcSEcCtD
Voriconazole—Palpitations—Epirubicin—pancreatic cancer	4.68e-05	0.000202	CcSEcCtD
Voriconazole—Loss of consciousness—Epirubicin—pancreatic cancer	4.66e-05	0.000201	CcSEcCtD
Voriconazole—Cough—Epirubicin—pancreatic cancer	4.63e-05	0.0002	CcSEcCtD
Voriconazole—Vision blurred—Doxorubicin—pancreatic cancer	4.62e-05	0.0002	CcSEcCtD
Voriconazole—Asthenia—Docetaxel—pancreatic cancer	4.6e-05	0.000199	CcSEcCtD
Voriconazole—Convulsion—Epirubicin—pancreatic cancer	4.59e-05	0.000198	CcSEcCtD
Voriconazole—Hypertension—Epirubicin—pancreatic cancer	4.58e-05	0.000198	CcSEcCtD
Voriconazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.55e-05	0.000197	CcSEcCtD
Voriconazole—Pruritus—Docetaxel—pancreatic cancer	4.54e-05	0.000196	CcSEcCtD
Voriconazole—Anaemia—Doxorubicin—pancreatic cancer	4.53e-05	0.000196	CcSEcCtD
Voriconazole—Myalgia—Epirubicin—pancreatic cancer	4.51e-05	0.000195	CcSEcCtD
Voriconazole—Chest pain—Epirubicin—pancreatic cancer	4.51e-05	0.000195	CcSEcCtD
Voriconazole—Arthralgia—Epirubicin—pancreatic cancer	4.51e-05	0.000195	CcSEcCtD
Voriconazole—Agitation—Doxorubicin—pancreatic cancer	4.51e-05	0.000195	CcSEcCtD
Voriconazole—Anxiety—Epirubicin—pancreatic cancer	4.5e-05	0.000194	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	4.48e-05	0.000194	CcSEcCtD
Voriconazole—Discomfort—Epirubicin—pancreatic cancer	4.46e-05	0.000193	CcSEcCtD
Voriconazole—Malaise—Doxorubicin—pancreatic cancer	4.42e-05	0.000191	CcSEcCtD
Voriconazole—Dry mouth—Epirubicin—pancreatic cancer	4.41e-05	0.000191	CcSEcCtD
Voriconazole—Vertigo—Doxorubicin—pancreatic cancer	4.41e-05	0.00019	CcSEcCtD
Voriconazole—Syncope—Doxorubicin—pancreatic cancer	4.4e-05	0.00019	CcSEcCtD
Voriconazole—Leukopenia—Doxorubicin—pancreatic cancer	4.39e-05	0.00019	CcSEcCtD
Voriconazole—Diarrhoea—Docetaxel—pancreatic cancer	4.39e-05	0.00019	CcSEcCtD
Voriconazole—Confusional state—Epirubicin—pancreatic cancer	4.36e-05	0.000188	CcSEcCtD
Voriconazole—Palpitations—Doxorubicin—pancreatic cancer	4.33e-05	0.000187	CcSEcCtD
Voriconazole—Oedema—Epirubicin—pancreatic cancer	4.33e-05	0.000187	CcSEcCtD
Voriconazole—Anaphylactic shock—Epirubicin—pancreatic cancer	4.33e-05	0.000187	CcSEcCtD
Voriconazole—Loss of consciousness—Doxorubicin—pancreatic cancer	4.31e-05	0.000186	CcSEcCtD
Voriconazole—Infection—Epirubicin—pancreatic cancer	4.3e-05	0.000186	CcSEcCtD
Voriconazole—Cough—Doxorubicin—pancreatic cancer	4.28e-05	0.000185	CcSEcCtD
Voriconazole—Shock—Epirubicin—pancreatic cancer	4.26e-05	0.000184	CcSEcCtD
Voriconazole—Convulsion—Doxorubicin—pancreatic cancer	4.25e-05	0.000184	CcSEcCtD
Voriconazole—Nervous system disorder—Epirubicin—pancreatic cancer	4.24e-05	0.000183	CcSEcCtD
Voriconazole—Dizziness—Docetaxel—pancreatic cancer	4.24e-05	0.000183	CcSEcCtD
Voriconazole—Thrombocytopenia—Epirubicin—pancreatic cancer	4.24e-05	0.000183	CcSEcCtD
Voriconazole—Hypertension—Doxorubicin—pancreatic cancer	4.23e-05	0.000183	CcSEcCtD
Voriconazole—Tachycardia—Epirubicin—pancreatic cancer	4.22e-05	0.000182	CcSEcCtD
Voriconazole—Skin disorder—Epirubicin—pancreatic cancer	4.2e-05	0.000182	CcSEcCtD
Voriconazole—Hyperhidrosis—Epirubicin—pancreatic cancer	4.18e-05	0.000181	CcSEcCtD
Voriconazole—Arthralgia—Doxorubicin—pancreatic cancer	4.18e-05	0.00018	CcSEcCtD
Voriconazole—Myalgia—Doxorubicin—pancreatic cancer	4.18e-05	0.00018	CcSEcCtD
Voriconazole—Chest pain—Doxorubicin—pancreatic cancer	4.18e-05	0.00018	CcSEcCtD
Voriconazole—Anxiety—Doxorubicin—pancreatic cancer	4.16e-05	0.00018	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	4.15e-05	0.000179	CcSEcCtD
Voriconazole—Discomfort—Doxorubicin—pancreatic cancer	4.13e-05	0.000178	CcSEcCtD
Voriconazole—Anorexia—Epirubicin—pancreatic cancer	4.12e-05	0.000178	CcSEcCtD
Voriconazole—Dry mouth—Doxorubicin—pancreatic cancer	4.08e-05	0.000176	CcSEcCtD
Voriconazole—Vomiting—Docetaxel—pancreatic cancer	4.08e-05	0.000176	CcSEcCtD
Voriconazole—Rash—Docetaxel—pancreatic cancer	4.04e-05	0.000175	CcSEcCtD
Voriconazole—Hypotension—Epirubicin—pancreatic cancer	4.04e-05	0.000175	CcSEcCtD
Voriconazole—Dermatitis—Docetaxel—pancreatic cancer	4.04e-05	0.000175	CcSEcCtD
Voriconazole—Confusional state—Doxorubicin—pancreatic cancer	4.04e-05	0.000174	CcSEcCtD
Voriconazole—Headache—Docetaxel—pancreatic cancer	4.02e-05	0.000174	CcSEcCtD
Voriconazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	4e-05	0.000173	CcSEcCtD
Voriconazole—Oedema—Doxorubicin—pancreatic cancer	4e-05	0.000173	CcSEcCtD
Voriconazole—Infection—Doxorubicin—pancreatic cancer	3.98e-05	0.000172	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.94e-05	0.00017	CcSEcCtD
Voriconazole—Shock—Doxorubicin—pancreatic cancer	3.94e-05	0.00017	CcSEcCtD
Voriconazole—Nervous system disorder—Doxorubicin—pancreatic cancer	3.93e-05	0.00017	CcSEcCtD
Voriconazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.92e-05	0.000169	CcSEcCtD
Voriconazole—Insomnia—Epirubicin—pancreatic cancer	3.91e-05	0.000169	CcSEcCtD
Voriconazole—Tachycardia—Doxorubicin—pancreatic cancer	3.91e-05	0.000169	CcSEcCtD
Voriconazole—Skin disorder—Doxorubicin—pancreatic cancer	3.89e-05	0.000168	CcSEcCtD
Voriconazole—Paraesthesia—Epirubicin—pancreatic cancer	3.88e-05	0.000168	CcSEcCtD
Voriconazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.87e-05	0.000167	CcSEcCtD
Voriconazole—Dyspnoea—Epirubicin—pancreatic cancer	3.86e-05	0.000167	CcSEcCtD
Voriconazole—Somnolence—Epirubicin—pancreatic cancer	3.85e-05	0.000166	CcSEcCtD
Voriconazole—Anorexia—Doxorubicin—pancreatic cancer	3.82e-05	0.000165	CcSEcCtD
Voriconazole—Nausea—Docetaxel—pancreatic cancer	3.81e-05	0.000165	CcSEcCtD
Voriconazole—Dyspepsia—Epirubicin—pancreatic cancer	3.81e-05	0.000165	CcSEcCtD
Voriconazole—Decreased appetite—Epirubicin—pancreatic cancer	3.76e-05	0.000163	CcSEcCtD
Voriconazole—Hypotension—Doxorubicin—pancreatic cancer	3.74e-05	0.000162	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.74e-05	0.000161	CcSEcCtD
Voriconazole—Pain—Epirubicin—pancreatic cancer	3.7e-05	0.00016	CcSEcCtD
Voriconazole—Constipation—Epirubicin—pancreatic cancer	3.7e-05	0.00016	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.65e-05	0.000158	CcSEcCtD
Voriconazole—Insomnia—Doxorubicin—pancreatic cancer	3.62e-05	0.000156	CcSEcCtD
Voriconazole—Paraesthesia—Doxorubicin—pancreatic cancer	3.59e-05	0.000155	CcSEcCtD
Voriconazole—Dyspnoea—Doxorubicin—pancreatic cancer	3.57e-05	0.000154	CcSEcCtD
Voriconazole—Feeling abnormal—Epirubicin—pancreatic cancer	3.57e-05	0.000154	CcSEcCtD
Voriconazole—Somnolence—Doxorubicin—pancreatic cancer	3.56e-05	0.000154	CcSEcCtD
Voriconazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.54e-05	0.000153	CcSEcCtD
Voriconazole—Dyspepsia—Doxorubicin—pancreatic cancer	3.52e-05	0.000152	CcSEcCtD
Voriconazole—Decreased appetite—Doxorubicin—pancreatic cancer	3.48e-05	0.00015	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.46e-05	0.000149	CcSEcCtD
Voriconazole—Urticaria—Epirubicin—pancreatic cancer	3.44e-05	0.000149	CcSEcCtD
Voriconazole—Pain—Doxorubicin—pancreatic cancer	3.42e-05	0.000148	CcSEcCtD
Voriconazole—Constipation—Doxorubicin—pancreatic cancer	3.42e-05	0.000148	CcSEcCtD
Voriconazole—Abdominal pain—Epirubicin—pancreatic cancer	3.42e-05	0.000148	CcSEcCtD
Voriconazole—Body temperature increased—Epirubicin—pancreatic cancer	3.42e-05	0.000148	CcSEcCtD
Voriconazole—Feeling abnormal—Doxorubicin—pancreatic cancer	3.3e-05	0.000143	CcSEcCtD
Voriconazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.27e-05	0.000141	CcSEcCtD
Voriconazole—Hypersensitivity—Epirubicin—pancreatic cancer	3.19e-05	0.000138	CcSEcCtD
Voriconazole—Urticaria—Doxorubicin—pancreatic cancer	3.18e-05	0.000137	CcSEcCtD
Voriconazole—Abdominal pain—Doxorubicin—pancreatic cancer	3.16e-05	0.000137	CcSEcCtD
Voriconazole—Body temperature increased—Doxorubicin—pancreatic cancer	3.16e-05	0.000137	CcSEcCtD
Voriconazole—Asthenia—Epirubicin—pancreatic cancer	3.1e-05	0.000134	CcSEcCtD
Voriconazole—Pruritus—Epirubicin—pancreatic cancer	3.06e-05	0.000132	CcSEcCtD
Voriconazole—Diarrhoea—Epirubicin—pancreatic cancer	2.96e-05	0.000128	CcSEcCtD
Voriconazole—Hypersensitivity—Doxorubicin—pancreatic cancer	2.95e-05	0.000127	CcSEcCtD
Voriconazole—Asthenia—Doxorubicin—pancreatic cancer	2.87e-05	0.000124	CcSEcCtD
Voriconazole—Dizziness—Epirubicin—pancreatic cancer	2.86e-05	0.000124	CcSEcCtD
Voriconazole—Pruritus—Doxorubicin—pancreatic cancer	2.83e-05	0.000122	CcSEcCtD
Voriconazole—Vomiting—Epirubicin—pancreatic cancer	2.75e-05	0.000119	CcSEcCtD
Voriconazole—Diarrhoea—Doxorubicin—pancreatic cancer	2.74e-05	0.000118	CcSEcCtD
Voriconazole—Rash—Epirubicin—pancreatic cancer	2.73e-05	0.000118	CcSEcCtD
Voriconazole—Dermatitis—Epirubicin—pancreatic cancer	2.73e-05	0.000118	CcSEcCtD
Voriconazole—Headache—Epirubicin—pancreatic cancer	2.71e-05	0.000117	CcSEcCtD
Voriconazole—Dizziness—Doxorubicin—pancreatic cancer	2.65e-05	0.000114	CcSEcCtD
Voriconazole—Nausea—Epirubicin—pancreatic cancer	2.57e-05	0.000111	CcSEcCtD
Voriconazole—Vomiting—Doxorubicin—pancreatic cancer	2.55e-05	0.00011	CcSEcCtD
Voriconazole—Rash—Doxorubicin—pancreatic cancer	2.52e-05	0.000109	CcSEcCtD
Voriconazole—Dermatitis—Doxorubicin—pancreatic cancer	2.52e-05	0.000109	CcSEcCtD
Voriconazole—Headache—Doxorubicin—pancreatic cancer	2.51e-05	0.000108	CcSEcCtD
Voriconazole—Nausea—Doxorubicin—pancreatic cancer	2.38e-05	0.000103	CcSEcCtD
